Comment on: Evaluation of the Utility of Baseline Echocardiogram in Patients With Standard‐Risk Precursor B‐Lymphoblastic Leukaemia
Pediatric Blood & Cancer · 2026-10 · 73 (10)
DOI: 10.1002/1545-5017.70531 ↗Kurz gefasst
Leserbrief in der Zeitschrift Pediatric Blood & Cancer, online erschienen am 17.08.2026. Verfasst von Samir Iddir und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Nedir Mohamed University Hospital Center, Tizi-Ouzou, Algeria. Die Arbeit nennt 8 Literaturangaben.
Abstract (Originalsprache)
The authors declare no conflicts of interest. Data sharing not applicable to this article as no datasets were generated or analysed during the current study.
Autor:innen und Institutionen
- Department of Pediatrics, Nedir Mohamed University Hospital Center, Tizi-Ouzou, Algeria.
- Faculty of Medicine, Mouloud Mammeri University, Tizi-Ouzou, Algeria.
- Department of Pediatrics Oncology, Draa Ben Khedda Cancer Center, Tizi-Ouzou, Algeria.
- Department of Medical Oncology, University of Laghouat, Laghouat, Laghouat Province, Algeria.
ORCID-Profile: Samir Iddir, Massinissa Benyagoub
Zitieren
APA
Iddir, S., Lounis, B., Benyagoub, M., & Benlahreche, Z. B. (2026). Comment on: Evaluation of the Utility of Baseline Echocardiogram in Patients With Standard‐Risk Precursor B‐Lymphoblastic Leukaemia. Pediatric Blood & Cancer, 73(10). https://doi.org/10.1002/1545-5017.70531
Vancouver
Iddir S, Lounis B, Benyagoub M, Benlahreche ZB. Comment on: Evaluation of the Utility of Baseline Echocardiogram in Patients With Standard‐Risk Precursor B‐Lymphoblastic Leukaemia. Pediatric Blood & Cancer. 2026;73(10). doi:10.1002/1545-5017.70531
BibTeX
@article{Iddir2026,
author = {Iddir, Samir and Lounis, Brahim and Benyagoub, Massinissa and Benlahreche, Zakia Batoul},
title = {Comment on: Evaluation of the Utility of Baseline Echocardiogram in Patients With Standard‐Risk Precursor B‐Lymphoblastic Leukaemia},
journal = {Pediatric Blood & Cancer},
year = {2026},
volume = {73},
number = {10},
doi = {10.1002/1545-5017.70531}
}
EUVIMED